Hold Rating on Henry Schein Amid KKR Investment and Market Uncertainties
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Mizuho raises Henry Schein stock target to $78, keeps neutral stance
Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...
A.O. Smith forecasts annual profit below estimates on weak water heater demand
Water heater maker A. O. Smith forecast full-year profit below estimates and also missed fourth-quarter profit expectations on Thursday, hurt by lower sales of its water heaters in North America and ...
Tectonic Therapeutic stock soars on positive trial data
The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...
MarketWatch15h
U.K. 30 Year Gilt
China 30 Year Government Bond 0.0000 1.8592% ...